David Sinclair just told Joe Rogan he takes Viagra every day for his hair.
Then he dropped the real twist. The same class of drugs (low-dose tadalafil) is turning up in cancer data, stripping the immune shield tumors hide behind and blocking how cancer cells use cholesterol.
That casual pivot was pleasantly surprising to me. A molecule we wrote off as a bedroom drug is quietly rewriting maps of immune surveillance, lipid trafficking, and even scalp perfusion at the same time.
Biology refuses the neat boxes we drew for it. Most side effects were never side effects. They were just the parts of the system we had not bothered to measure yet.
Human trials (especially head-and-neck) and multiple mouse models confirm tadalafil reduces myeloid-derived suppressor cells and restores T-cell access to tumors. A July 2026 Cancer Research paper showed sildenafil (same PDE5 class) traps cholesterol inside lysosomes via cGMP, limiting metastasis, an effect expected across the class. Hair evidence is still mostly mechanistic. Promising signals, not settled prevention.
Viagra and its analogues are still mainly linked to the bedroom in most people’s minds. But with cancer rates rising in younger people, every possible avenue is worth exploring. We cannot afford to overlook tools just because of the box we first put them in.
Video